Medical Care

Global Toxicology Drug Screening Market Research Report 2025

The global market for Toxicology Drug Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Toxicology Drug Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxicology Drug Screening.
The Toxicology Drug Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Toxicology Drug Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Toxicology Drug Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Merck
Bio-Rad Laboratories Inc.
Danaher
Charles River Laboratories International Inc.
Enzo Life Sciences Inc.
Eurofins Scientific
Selvita
Laboratory Corporation of America Holdings
Promega Corporation
The Jackson Laboratory
Agilent Technologies, Inc
Waters
TECHCOMP GROUP
Wuxi AppTec
Segment by Type
Cardiovascular Disease Drug Screening
Obesity Drug Screening
Diabetes Drug Screening
Others
Segment by Application
Hospitals
Clinics
Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Toxicology Drug Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Toxicology Drug Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cardiovascular Disease Drug Screening
1.2.3 Obesity Drug Screening
1.2.4 Diabetes Drug Screening
1.2.5 Others
1.3 Market by Application
1.3.1 Global Toxicology Drug Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Toxicology Drug Screening Market Perspective (2020-2031)
2.2 Global Toxicology Drug Screening Growth Trends by Region
2.2.1 Global Toxicology Drug Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Toxicology Drug Screening Historic Market Size by Region (2020-2025)
2.2.3 Toxicology Drug Screening Forecasted Market Size by Region (2026-2031)
2.3 Toxicology Drug Screening Market Dynamics
2.3.1 Toxicology Drug Screening Industry Trends
2.3.2 Toxicology Drug Screening Market Drivers
2.3.3 Toxicology Drug Screening Market Challenges
2.3.4 Toxicology Drug Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Toxicology Drug Screening Players by Revenue
3.1.1 Global Top Toxicology Drug Screening Players by Revenue (2020-2025)
3.1.2 Global Toxicology Drug Screening Revenue Market Share by Players (2020-2025)
3.2 Global Toxicology Drug Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Toxicology Drug Screening Revenue
3.4 Global Toxicology Drug Screening Market Concentration Ratio
3.4.1 Global Toxicology Drug Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Toxicology Drug Screening Revenue in 2024
3.5 Global Key Players of Toxicology Drug Screening Head office and Area Served
3.6 Global Key Players of Toxicology Drug Screening, Product and Application
3.7 Global Key Players of Toxicology Drug Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Toxicology Drug Screening Breakdown Data by Type
4.1 Global Toxicology Drug Screening Historic Market Size by Type (2020-2025)
4.2 Global Toxicology Drug Screening Forecasted Market Size by Type (2026-2031)
5 Toxicology Drug Screening Breakdown Data by Application
5.1 Global Toxicology Drug Screening Historic Market Size by Application (2020-2025)
5.2 Global Toxicology Drug Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Toxicology Drug Screening Market Size (2020-2031)
6.2 North America Toxicology Drug Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Toxicology Drug Screening Market Size by Country (2020-2025)
6.4 North America Toxicology Drug Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Toxicology Drug Screening Market Size (2020-2031)
7.2 Europe Toxicology Drug Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Toxicology Drug Screening Market Size by Country (2020-2025)
7.4 Europe Toxicology Drug Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Toxicology Drug Screening Market Size (2020-2031)
8.2 Asia-Pacific Toxicology Drug Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Toxicology Drug Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Toxicology Drug Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Toxicology Drug Screening Market Size (2020-2031)
9.2 Latin America Toxicology Drug Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Toxicology Drug Screening Market Size by Country (2020-2025)
9.4 Latin America Toxicology Drug Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Toxicology Drug Screening Market Size (2020-2031)
10.2 Middle East & Africa Toxicology Drug Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Toxicology Drug Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Toxicology Drug Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Details
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Toxicology Drug Screening Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Toxicology Drug Screening Business (2020-2025)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Toxicology Drug Screening Introduction
11.2.4 Merck Revenue in Toxicology Drug Screening Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Bio-Rad Laboratories Inc.
11.3.1 Bio-Rad Laboratories Inc. Company Details
11.3.2 Bio-Rad Laboratories Inc. Business Overview
11.3.3 Bio-Rad Laboratories Inc. Toxicology Drug Screening Introduction
11.3.4 Bio-Rad Laboratories Inc. Revenue in Toxicology Drug Screening Business (2020-2025)
11.3.5 Bio-Rad Laboratories Inc. Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher Toxicology Drug Screening Introduction
11.4.4 Danaher Revenue in Toxicology Drug Screening Business (2020-2025)
11.4.5 Danaher Recent Development
11.5 Charles River Laboratories International Inc.
11.5.1 Charles River Laboratories International Inc. Company Details
11.5.2 Charles River Laboratories International Inc. Business Overview
11.5.3 Charles River Laboratories International Inc. Toxicology Drug Screening Introduction
11.5.4 Charles River Laboratories International Inc. Revenue in Toxicology Drug Screening Business (2020-2025)
11.5.5 Charles River Laboratories International Inc. Recent Development
11.6 Enzo Life Sciences Inc.
11.6.1 Enzo Life Sciences Inc. Company Details
11.6.2 Enzo Life Sciences Inc. Business Overview
11.6.3 Enzo Life Sciences Inc. Toxicology Drug Screening Introduction
11.6.4 Enzo Life Sciences Inc. Revenue in Toxicology Drug Screening Business (2020-2025)
11.6.5 Enzo Life Sciences Inc. Recent Development
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Details
11.7.2 Eurofins Scientific Business Overview
11.7.3 Eurofins Scientific Toxicology Drug Screening Introduction
11.7.4 Eurofins Scientific Revenue in Toxicology Drug Screening Business (2020-2025)
11.7.5 Eurofins Scientific Recent Development
11.8 Selvita
11.8.1 Selvita Company Details
11.8.2 Selvita Business Overview
11.8.3 Selvita Toxicology Drug Screening Introduction
11.8.4 Selvita Revenue in Toxicology Drug Screening Business (2020-2025)
11.8.5 Selvita Recent Development
11.9 Laboratory Corporation of America Holdings
11.9.1 Laboratory Corporation of America Holdings Company Details
11.9.2 Laboratory Corporation of America Holdings Business Overview
11.9.3 Laboratory Corporation of America Holdings Toxicology Drug Screening Introduction
11.9.4 Laboratory Corporation of America Holdings Revenue in Toxicology Drug Screening Business (2020-2025)
11.9.5 Laboratory Corporation of America Holdings Recent Development
11.10 Promega Corporation
11.10.1 Promega Corporation Company Details
11.10.2 Promega Corporation Business Overview
11.10.3 Promega Corporation Toxicology Drug Screening Introduction
11.10.4 Promega Corporation Revenue in Toxicology Drug Screening Business (2020-2025)
11.10.5 Promega Corporation Recent Development
11.11 The Jackson Laboratory
11.11.1 The Jackson Laboratory Company Details
11.11.2 The Jackson Laboratory Business Overview
11.11.3 The Jackson Laboratory Toxicology Drug Screening Introduction
11.11.4 The Jackson Laboratory Revenue in Toxicology Drug Screening Business (2020-2025)
11.11.5 The Jackson Laboratory Recent Development
11.12 Agilent Technologies, Inc
11.12.1 Agilent Technologies, Inc Company Details
11.12.2 Agilent Technologies, Inc Business Overview
11.12.3 Agilent Technologies, Inc Toxicology Drug Screening Introduction
11.12.4 Agilent Technologies, Inc Revenue in Toxicology Drug Screening Business (2020-2025)
11.12.5 Agilent Technologies, Inc Recent Development
11.13 Waters
11.13.1 Waters Company Details
11.13.2 Waters Business Overview
11.13.3 Waters Toxicology Drug Screening Introduction
11.13.4 Waters Revenue in Toxicology Drug Screening Business (2020-2025)
11.13.5 Waters Recent Development
11.14 TECHCOMP GROUP
11.14.1 TECHCOMP GROUP Company Details
11.14.2 TECHCOMP GROUP Business Overview
11.14.3 TECHCOMP GROUP Toxicology Drug Screening Introduction
11.14.4 TECHCOMP GROUP Revenue in Toxicology Drug Screening Business (2020-2025)
11.14.5 TECHCOMP GROUP Recent Development
11.15 Wuxi AppTec
11.15.1 Wuxi AppTec Company Details
11.15.2 Wuxi AppTec Business Overview
11.15.3 Wuxi AppTec Toxicology Drug Screening Introduction
11.15.4 Wuxi AppTec Revenue in Toxicology Drug Screening Business (2020-2025)
11.15.5 Wuxi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Toxicology Drug Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cardiovascular Disease Drug Screening
Table 3. Key Players of Obesity Drug Screening
Table 4. Key Players of Diabetes Drug Screening
Table 5. Key Players of Others
Table 6. Global Toxicology Drug Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Toxicology Drug Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Toxicology Drug Screening Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Toxicology Drug Screening Market Share by Region (2020-2025)
Table 10. Global Toxicology Drug Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Toxicology Drug Screening Market Share by Region (2026-2031)
Table 12. Toxicology Drug Screening Market Trends
Table 13. Toxicology Drug Screening Market Drivers
Table 14. Toxicology Drug Screening Market Challenges
Table 15. Toxicology Drug Screening Market Restraints
Table 16. Global Toxicology Drug Screening Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Toxicology Drug Screening Market Share by Players (2020-2025)
Table 18. Global Top Toxicology Drug Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxicology Drug Screening as of 2024)
Table 19. Ranking of Global Top Toxicology Drug Screening Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Toxicology Drug Screening Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Toxicology Drug Screening, Headquarters and Area Served
Table 22. Global Key Players of Toxicology Drug Screening, Product and Application
Table 23. Global Key Players of Toxicology Drug Screening, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Toxicology Drug Screening Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Toxicology Drug Screening Revenue Market Share by Type (2020-2025)
Table 27. Global Toxicology Drug Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Toxicology Drug Screening Revenue Market Share by Type (2026-2031)
Table 29. Global Toxicology Drug Screening Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Toxicology Drug Screening Revenue Market Share by Application (2020-2025)
Table 31. Global Toxicology Drug Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Toxicology Drug Screening Revenue Market Share by Application (2026-2031)
Table 33. North America Toxicology Drug Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Toxicology Drug Screening Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Toxicology Drug Screening Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Toxicology Drug Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Toxicology Drug Screening Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Toxicology Drug Screening Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Toxicology Drug Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Toxicology Drug Screening Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Toxicology Drug Screening Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Toxicology Drug Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Toxicology Drug Screening Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Toxicology Drug Screening Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Toxicology Drug Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Toxicology Drug Screening Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Toxicology Drug Screening Market Size by Country (2026-2031) & (US$ Million)
Table 48. Thermo Fisher Scientific Inc. Company Details
Table 49. Thermo Fisher Scientific Inc. Business Overview
Table 50. Thermo Fisher Scientific Inc. Toxicology Drug Screening Product
Table 51. Thermo Fisher Scientific Inc. Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 52. Thermo Fisher Scientific Inc. Recent Development
Table 53. Merck Company Details
Table 54. Merck Business Overview
Table 55. Merck Toxicology Drug Screening Product
Table 56. Merck Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 57. Merck Recent Development
Table 58. Bio-Rad Laboratories Inc. Company Details
Table 59. Bio-Rad Laboratories Inc. Business Overview
Table 60. Bio-Rad Laboratories Inc. Toxicology Drug Screening Product
Table 61. Bio-Rad Laboratories Inc. Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 62. Bio-Rad Laboratories Inc. Recent Development
Table 63. Danaher Company Details
Table 64. Danaher Business Overview
Table 65. Danaher Toxicology Drug Screening Product
Table 66. Danaher Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 67. Danaher Recent Development
Table 68. Charles River Laboratories International Inc. Company Details
Table 69. Charles River Laboratories International Inc. Business Overview
Table 70. Charles River Laboratories International Inc. Toxicology Drug Screening Product
Table 71. Charles River Laboratories International Inc. Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 72. Charles River Laboratories International Inc. Recent Development
Table 73. Enzo Life Sciences Inc. Company Details
Table 74. Enzo Life Sciences Inc. Business Overview
Table 75. Enzo Life Sciences Inc. Toxicology Drug Screening Product
Table 76. Enzo Life Sciences Inc. Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 77. Enzo Life Sciences Inc. Recent Development
Table 78. Eurofins Scientific Company Details
Table 79. Eurofins Scientific Business Overview
Table 80. Eurofins Scientific Toxicology Drug Screening Product
Table 81. Eurofins Scientific Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 82. Eurofins Scientific Recent Development
Table 83. Selvita Company Details
Table 84. Selvita Business Overview
Table 85. Selvita Toxicology Drug Screening Product
Table 86. Selvita Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 87. Selvita Recent Development
Table 88. Laboratory Corporation of America Holdings Company Details
Table 89. Laboratory Corporation of America Holdings Business Overview
Table 90. Laboratory Corporation of America Holdings Toxicology Drug Screening Product
Table 91. Laboratory Corporation of America Holdings Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 92. Laboratory Corporation of America Holdings Recent Development
Table 93. Promega Corporation Company Details
Table 94. Promega Corporation Business Overview
Table 95. Promega Corporation Toxicology Drug Screening Product
Table 96. Promega Corporation Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 97. Promega Corporation Recent Development
Table 98. The Jackson Laboratory Company Details
Table 99. The Jackson Laboratory Business Overview
Table 100. The Jackson Laboratory Toxicology Drug Screening Product
Table 101. The Jackson Laboratory Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 102. The Jackson Laboratory Recent Development
Table 103. Agilent Technologies, Inc Company Details
Table 104. Agilent Technologies, Inc Business Overview
Table 105. Agilent Technologies, Inc Toxicology Drug Screening Product
Table 106. Agilent Technologies, Inc Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 107. Agilent Technologies, Inc Recent Development
Table 108. Waters Company Details
Table 109. Waters Business Overview
Table 110. Waters Toxicology Drug Screening Product
Table 111. Waters Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 112. Waters Recent Development
Table 113. TECHCOMP GROUP Company Details
Table 114. TECHCOMP GROUP Business Overview
Table 115. TECHCOMP GROUP Toxicology Drug Screening Product
Table 116. TECHCOMP GROUP Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 117. TECHCOMP GROUP Recent Development
Table 118. Wuxi AppTec Company Details
Table 119. Wuxi AppTec Business Overview
Table 120. Wuxi AppTec Toxicology Drug Screening Product
Table 121. Wuxi AppTec Revenue in Toxicology Drug Screening Business (2020-2025) & (US$ Million)
Table 122. Wuxi AppTec Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report


List of Figures
Figure 1. Toxicology Drug Screening Picture
Figure 2. Global Toxicology Drug Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Toxicology Drug Screening Market Share by Type: 2024 VS 2031
Figure 4. Cardiovascular Disease Drug Screening Features
Figure 5. Obesity Drug Screening Features
Figure 6. Diabetes Drug Screening Features
Figure 7. Others Features
Figure 8. Global Toxicology Drug Screening Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Toxicology Drug Screening Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Laboratory Case Studies
Figure 13. Others Case Studies
Figure 14. Toxicology Drug Screening Report Years Considered
Figure 15. Global Toxicology Drug Screening Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Toxicology Drug Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Toxicology Drug Screening Market Share by Region: 2024 VS 2031
Figure 18. Global Toxicology Drug Screening Market Share by Players in 2024
Figure 19. Global Top Toxicology Drug Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxicology Drug Screening as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Toxicology Drug Screening Revenue in 2024
Figure 21. North America Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Toxicology Drug Screening Market Share by Country (2020-2031)
Figure 23. United States Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Toxicology Drug Screening Market Share by Country (2020-2031)
Figure 27. Germany Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Toxicology Drug Screening Market Share by Region (2020-2031)
Figure 35. China Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Toxicology Drug Screening Market Share by Country (2020-2031)
Figure 43. Mexico Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Toxicology Drug Screening Market Share by Country (2020-2031)
Figure 47. Turkey Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Toxicology Drug Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 52. Bio-Rad Laboratories Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 53. Danaher Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 54. Charles River Laboratories International Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 55. Enzo Life Sciences Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 56. Eurofins Scientific Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 57. Selvita Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 58. Laboratory Corporation of America Holdings Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 59. Promega Corporation Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 60. The Jackson Laboratory Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 61. Agilent Technologies, Inc Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 62. Waters Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 63. TECHCOMP GROUP Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 64. Wuxi AppTec Revenue Growth Rate in Toxicology Drug Screening Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies